SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-13-035264
Filing Date
2013-04-30
Accepted
2013-04-30 16:31:08
Documents
5
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a13-11111_110ka.htm 10-K/A 796253
2 EX-31.1 a13-11111_1ex31d1.htm EX-31.1 13874
3 EX-31.2 a13-11111_1ex31d2.htm EX-31.2 13839
4 EX-32.1 a13-11111_1ex32d1.htm EX-32.1 6863
5 EX-32.2 a13-11111_1ex32d2.htm EX-32.2 6801
  Complete submission text file 0001104659-13-035264.txt   838651
Mailing Address 5001 SOUTH MIAMI BOULEVARD SUITE 300 DURHAM NC 27703
Business Address 5001 SOUTH MIAMI BOULEVARD SUITE 300 DURHAM NC 27703 919 474 0020
TRANZYME INC (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35119 | Film No.: 13797981
SIC: 2834 Pharmaceutical Preparations